Skip to search formSkip to main contentSkip to account menu

PAK 200

Known as: 3-Pyridinecarboxylic acid, 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-1-(2-(4-morpholinyl)ethyl)-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl ester, P-oxide, dihydrochloride, PAK-200, PAK-200S 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dihydropyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Augmentation of the Activity of an Immunotoxin, Anti-Tac(Fv)-PE40KDEL, in T Cell Lines Infected with Human T Cell Leukemia Virus Type-I
Therapy with an immunotoxin, anti-Tac(Fv)-PE38, which is a conjugate of the variable domains of an anti-Tac monoclonal antibody… 
1992
1992
Potentiation of the Vincristine Effect on P388 Mouse Leukemia Cells by a Newly Synthesized Dihydropyridine Analogue, PAK‐200
A newly synthesized dihydropyridine analogue, 2‐[benzyl(phenyl)amino]ethyl 1,4‐dihydrb‐2,6‐dimethyl‐5‐(5,5‐dimethyl‐2‐oxo‐l,3,2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)